Related Experiment Video
Updated: Sep 10, 2025
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
The validity and reliability of the turkish version of the constipation risk assessment scale in cancers
Yücel Olgun1, Ömer Faruk Tarhan2, Rekib Saçaklıdır3
1Division of Pain Medicine, Deparment of Physical Medicine and Rehabilitation, Ağrı Training and Research Hospital, Ağrı, Türkiye.
Objectives:
Cancer increases the incidence of constipation. The best way to prevent constipation is to detect it before it develops. Therefore, it is very important to use valid and reliable scales that assess the risk of constipation in order to prevent its occurrence in cancer patients. This study aims to assess the validity and reliability of the Constipation Risk Assessment Scale (CRAS) when applied to the Turkish population with cancer.
Methods:
A total of 102 outpatients with cancer were included in the study. According to the Rome IV criteria, participants were divided into two groups: constipated and non-constipated. All patients were evaluated using the CRAS. A subset of patients was randomly selected for retesting with the CRAS.
Results:
In the evaluation of the test-retest reliability of the CRAS, Cronbach's alpha coefficient and intraclass correlation coefficient (ICC) values were found to be 0.97 (0.93-0.99) for the total CRAS score and between 0.83 (0.64-0.94) and 0.96 (0.92-0.97) for the subscales. The retest reliability was found to be high (p<0.001). Significant correlations were observed between the total CRAS score and all subscales with the Rome IV criteria, as well as between the CRAS medication subscale and the Rome IV criteria.
Conclusion:
The present study showed that the Turkish version of the CRAS is a valid and reliable tool for use with outpatients with cancer. The CRAS can be effectively utilized to identify individuals at risk of constipation and to develop targeted prevention programs. Healthcare professionals can use the Turkish version of the CRAS as a reliable tool to assess constipation risk among cancer patients.
More Related Videos
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
01:25Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
01:29Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
01:17Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
01:30Serum Laboratory Studies, Stool Test, Breath Test
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:29Reliability and Validity